These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17640595)

  • 1. Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation.
    Tey SK; Dotti G; Rooney CM; Heslop HE; Brenner MK
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):913-24. PubMed ID: 17640595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation.
    Zhou X; Dotti G; Krance RA; Martinez CA; Naik S; Kamble RT; Durett AG; Dakhova O; Savoldo B; Di Stasi A; Spencer DM; Lin YF; Liu H; Grilley BJ; Gee AP; Rooney CM; Heslop HE; Brenner MK
    Blood; 2015 Jun; 125(26):4103-13. PubMed ID: 25977584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible apoptosis as a safety switch for adoptive cell therapy.
    Di Stasi A; Tey SK; Dotti G; Fujita Y; Kennedy-Nasser A; Martinez C; Straathof K; Liu E; Durett AG; Grilley B; Liu H; Cruz CR; Savoldo B; Gee AP; Schindler J; Krance RA; Heslop HE; Spencer DM; Rooney CM; Brenner MK
    N Engl J Med; 2011 Nov; 365(18):1673-83. PubMed ID: 22047558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation.
    Perruccio K; Topini F; Tosti A; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2008; 40(1):76-83. PubMed ID: 17977031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene.
    Zhou X; Di Stasi A; Tey SK; Krance RA; Martinez C; Leung KS; Durett AG; Wu MF; Liu H; Leen AM; Savoldo B; Lin YF; Grilley BJ; Gee AP; Spencer DM; Rooney CM; Heslop HE; Brenner MK; Dotti G
    Blood; 2014 Jun; 123(25):3895-905. PubMed ID: 24753538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation.
    Amrolia PJ; Muccioli-Casadei G; Huls H; Adams S; Durett A; Gee A; Yvon E; Weiss H; Cobbold M; Gaspar HB; Rooney C; Kuehnle I; Ghetie V; Schindler J; Krance R; Heslop HE; Veys P; Vitetta E; Brenner MK
    Blood; 2006 Sep; 108(6):1797-808. PubMed ID: 16741253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function.
    Robinet E; Fehse B; Ebeling S; Sauce D; Ferrand C; Tiberghien P
    Cytotherapy; 2005; 7(2):150-7. PubMed ID: 16040394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
    Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
    Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial Activation of the Inducible Caspase 9 Safety Switch After Human Stem Cell Transplantation.
    Zhou X; Naik S; Dakhova O; Dotti G; Heslop HE; Brenner MK
    Mol Ther; 2016 Apr; 24(4):823-31. PubMed ID: 26708005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T Cells.
    Zhang P; Raju J; Ullah MA; Au R; Varelias A; Gartlan KH; Olver SD; Samson LD; Sturgeon E; Zomerdijk N; Avery J; Gargett T; Brown MP; Coin LJ; Ganesamoorthy D; Hutchins C; Pratt GR; Kennedy GA; Morton AJ; Curley CI; Hill GR; Tey SK
    Clin Cancer Res; 2019 Mar; 25(6):1749-1755. PubMed ID: 30765390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
    Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
    Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation.
    Zhang P; Tey SK
    Front Immunol; 2019; 10():1854. PubMed ID: 31447852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses.
    Amrolia PJ; Muccioli-Casadei G; Yvon E; Huls H; Sili U; Wieder ED; Bollard C; Michalek J; Ghetie V; Heslop HE; Molldrem JJ; Rooney CM; Schlinder J; Vitetta E; Brenner MK
    Blood; 2003 Sep; 102(6):2292-9. PubMed ID: 12763937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicide-gene-Transduced donor T-cells for controlled graft-versus-host disease and graft-versus-tumor.
    Ciceri F; Bordignon C
    Int J Hematol; 2002 Nov; 76(4):305-9. PubMed ID: 12463592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated apoptosis of genetically modified hematopoietic stem and progenitor cells via an inducible caspase-9 suicide gene in rhesus macaques.
    Barese CN; Felizardo TC; Sellers SE; Keyvanfar K; Di Stasi A; Metzger ME; Krouse AE; Donahue RE; Spencer DM; Dunbar CE
    Stem Cells; 2015 Jan; 33(1):91-100. PubMed ID: 25330775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically engineered T-cells expressing a ganciclovir-sensitive HSV-tk suicide gene for the prevention of GvHD.
    Mailly L; Leboeuf C; Tiberghien P; Baumert T; Robinet E
    Curr Opin Investig Drugs; 2010 May; 11(5):559-70. PubMed ID: 20419602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide gene.
    Zhan H; Gilmour K; Chan L; Farzaneh F; McNicol AM; Xu JH; Adams S; Fehse B; Veys P; Thrasher A; Gaspar H; Qasim W
    PLoS One; 2013; 8(10):e77106. PubMed ID: 24204746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.